Sentinel laboratory surveillance of hepatitis C antibody testing in England: Understanding the epidemiology of HCV infection

Lisa J. Brant, M. Hurrelle, M. A. Balogun, P. Klapper, F. Ahmad, E. Boxall, A. Hale, V. Hollyoak, I. B. Ibrahim, W. Irving, R. Meigh, K. J. Mutton, B. C. Patel, W. K. Paver, S. Pugh, C. Taylor, A. J. Turner, Mary Ramsay

Research output: Contribution to journalArticlepeer-review

28 Citations (Scopus)

Abstract

This paper describes sentinel laboratory surveillance of hepatitis C antibody testing in England. Demographic and test result data were supplemented by follow-up questionnaires sent to the requesting clinician. Between October 2002 and September 2003 almost 75000 anti-HCV tests were performed in eight sentinel centres. More males were tested than females and over half of those tested were aged 25-44 years. Overall 5.7% (3333/58144, range 2.8-7.7%) individuals tested positive. Follow-up questionnaire data showed that 82% (1043/1277) of the positives had injecting drug use reported as the main risk exposure. The majority of negative individuals were undergoing routine screening as recommended for specific patient groups. Most individuals were asymptomatic. Antibody prevalence was estimated to be 34% in current injecting drug users and 42% in former injectors. Comparing positives to routine national surveillance suggests that only 53% (1782/3333) of diagnosed cases were reported. Sentinel laboratory data can provide valuable supplementary data to national surveillance.

Original languageEnglish
Pages (from-to)417-426
Number of pages10
JournalEpidemiology and Infection
Volume135
Issue number3
DOIs
Publication statusPublished - Apr 2007

Fingerprint

Dive into the research topics of 'Sentinel laboratory surveillance of hepatitis C antibody testing in England: Understanding the epidemiology of HCV infection'. Together they form a unique fingerprint.

Cite this